Wikidata

(Q63811787)

English

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

short name
BREEZE-AD5 (English)
0 references
title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Canada
0 references
main subject
dermatitis
0 references
atopic dermatitis
0 references
start time
20 February 2018
0 references
end time
17 October 2019
0 references
number of participants
450
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63811787&oldid=1857378948"